The PE is rich in the mid-50s, but has 20% revenue growth, and they have a revolutionary medical device, an insulin patch. Have a new CEO.
Stock price when the opinion was issued
Build your watch list
Sign in to track investmentsyou care about
Raymond James
Stockchase Premium
Selective Asset Management
ETF Capital Management Inc.
5i Research
The PE is rich in the mid-50s, but has 20% revenue growth, and they have a revolutionary medical device, an insulin patch. Have a new CEO.